Top compounds associated with response to MYO19


Feature Type Standardized
Nominal ANOVA
mRNA FK866 CTRPv2 pan-cancer AAC 0.075 0.06
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.057 0.06
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.065 0.06
mRNA KHS101 CTRPv2 pan-cancer AAC 0.073 0.06
mRNA lenalidomide FIMM pan-cancer AAC 0.32 0.06
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.068 0.06
mRNA PD-0325901 gCSI pan-cancer AAC 0.11 0.06
mRNA MLN2480 CTRPv2 pan-cancer AAC -0.1 0.06
mRNA Cytarabine GDSC1000 pan-cancer AAC 0.067 0.06
mRNA marinopyrrole A CTRPv2 pan-cancer AAC 0.087 0.06
Download CSV